-transparent.png){kind=logo}
BHK fibroblasts contain two forms of cyclic AMP phosphodiesterase 3':5'-cyclic nucleotide 5'-nucleotidohydrolase EC 3.1.4.17) as analyzed by linear sucrose gradient fractionation; a 3.6-S form (peak I) and a 6.7-S form (peak II). Peak I is specific for cyclic AMP as substrate and displays Michaelis-Menten kinetics with an apparent Km of 2--3 micrometer. Peak II hydrolyzes cyclic GMP and displays anomalous kinetics for cyclic AMP hydrolysis. The activity of isolated peak II for cyclic AMP is increased by storage at 4 degrees C, treatment with trypsin, or treatment with rat brain and BHK fibroblast activator proteins. The activity of isolated peak I is unaffected by these conditions. Linear sucrose gradient fractionation demonstrates that activation of peak II by trypsin leads to the formation of a 3.6-S cyclic AMP-specific enzyme form, possibly peak I. In contrast to BHK fibroblasts (and most other mammalian tissues), rat uterus contains only one form of cyclic nucleotide phosphodiesterase on linear sucrose gradients, a 7-S form capable of hydrolyzing both cyclic AMP and cyclic GMP. Treatment of rat uterine supernatant with trypsin leads to the appearance of a 4-S, cyclic AMP-specific form with properties similar to that of BHK peak I. These data suggest that the kinetically complex, higher molecular weight cyclic nucleotide phosphodiesterases may consist of more than one catalytically active site and that multiple forms of the enzyme arise through dissociative mechanisms, possibly as a means of in vivo regulation.
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
January 1985,
Journal of cyclic nucleotide and protein phosphorylation research,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
December 1997,
British journal of haematology,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
February 2003,
The Journal of biological chemistry,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
December 1979,
Analytical biochemistry,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
January 1984,
Advances in cyclic nucleotide and protein phosphorylation research,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
January 1984,
Advances in cyclic nucleotide and protein phosphorylation research,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
November 1974,
Arzneimittel-Forschung,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
July 1978,
Analytical biochemistry,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
April 1998,
Seminars in cell & developmental biology,
P M Epstein, and
W J Pledger, and
E A Gardner, and
G M Stancel, and
W J Thompson, and
S J Strada
January 1998,
Methods (San Diego, Calif.),
